Source:http://linkedlifedata.com/resource/pubmed/id/14136499
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1964-8-1
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/CHILD,
http://linkedlifedata.com/resource/pubmed/keyword/EPIDEMIOLOGY,
http://linkedlifedata.com/resource/pubmed/keyword/France,
http://linkedlifedata.com/resource/pubmed/keyword/POLIOMYELITIS,
http://linkedlifedata.com/resource/pubmed/keyword/POLIOVIRUS VACCINE, ORAL
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
OM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0001-4079
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
148
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
75-86
|
pubmed:dateRevised |
2011-9-15
|
pubmed:meshHeading | |
pubmed:articleTitle |
[USE OF HOMOTYPE ORAL ANTIPOLIOMYELITIC VACCINE DURING AN EPIDEMIC OCCURRING IN FRANCE AND DUE TO TYPE I POLIOMYELITIS VIRUS].
|
pubmed:publicationType |
Journal Article
|